Building a healthier community, one effort at a time

NanoEntek

Jul 18, 2023

3 min read

This article is written from the perspective of a diagnostic company.

Diagnostic companies play an important role in supporting public health, building healthier communities, and improving quality of life.

Following the global pandemic, public awareness of public health, disease prevention, and community well-being has increased significantly. Many countries have now eased travel restrictions and reopened their borders to international visitors.

However, returning to normal life after a pandemic that affected not only individuals but entire countries requires more than simply lifting restrictions. What efforts have been made to restore everyday life, protect public health, and prepare communities for future health challenges?

The key to building a healthier community

During the pandemic, the demand for diagnostic testing increased significantly as people needed to determine their infection status quickly and accurately. Large-scale diagnosis and testing were essential for providing appropriate treatment and implementing effective quarantine measures. In addition to the efforts of governments and diagnostic companies, voluntary self-testing also played an important role in reducing the spread of the virus.

Large-scale and simultaneous screening became possible through three major advancements made by diagnostic companies.

The future of diagnostic systems_The pathway to the new future and the challenges — Reference: The future of diagnostics, Deloitte

1. Early Detection and Prevention Technologies with High Accuracy

Diagnostic companies have developed innovative testing technologies that enable early and accurate detection using a single blood sample or a small amount of mucus. These technologies allow healthcare professionals to identify infections promptly, provide timely treatment, and reduce the risk of complications.

2. Strengthening the Supply Chain for Reliable Diagnostic Products

The quality of diagnostic materials is essential for reducing false-negative and false-positive results. By strengthening and expanding supply chains, diagnostic companies have supported the large-scale distribution of reliable testing products to healthcare professionals and individuals who need to confirm their infection status.

3. Developing Advanced Biomarker Detection Systems for Comprehensive Analysis

Making a clinical decision based on a single test result may not always provide sufficient information. Diagnostic companies offer a range of biomarker detection systems that support more comprehensive analysis, helping healthcare professionals make clearer medical decisions and select appropriate treatment options for patients.

As the pandemic era comes to an end, people may wonder how diagnostic companies will continue to contribute to public health. Human health is continuously monitored through diagnostic systems that provide valuable medical information from blood samples, secretions, and other biological materials.

How diagnostic companies can help save lives

In primary care and hospital settings, patients can check their hormone levels using a small blood sample. Target biomarkers in the plasma react with specific components in the diagnostic system, allowing healthcare professionals to measure their concentration. Routine health check-ups can also be performed using the same diagnostic approach.

Many biomarkers that may help identify diseases at an early stage are still being studied. Diagnostic systems do more than monitor a patient’s current health status. They can also support early disease detection, which may improve treatment outcomes and increase the chance of survival. Detecting a disease at an early stage can also help patients reduce the physical and financial burden of more advanced treatment.

Diagnostic companies can make their products more accessible and affordable by continuing to improve diagnostic technology. Diagnostic systems can be made smaller while maintaining accuracy, and testing procedures can be simplified to make them easier for users to understand. Lowering the cost of diagnostic systems can also improve access for low-income communities and regions with limited healthcare resources.

Mapping future paths to value_there are five ways to win the value game — Reference: The health care diagnostics value game, KPMG, 2018

In addition to supporting community health, diagnostic companies can organize educational sessions to raise health awareness and help vulnerable populations better understand self-health management. Public health initiatives can be delivered through health campaigns, screening programs, webinars, and social media content to increase awareness of specific health conditions.

Diagnostic companies with strong capabilities in data analysis and algorithm development can also provide tools for identifying patterns and trends in community health data. These insights can help support public health policies and guide more effective healthcare interventions. In addition, collected and refined health data may contribute to the discovery and development of new biomarkers.

Conclusion

Overall, diagnostic companies can support healthier communities by collaborating with healthcare providers, public health organizations, and local communities. Through these efforts, they can contribute to the development of new diagnostic technologies and more patient-centered diagnostic systems that support a healthier future.